|
EP3052091A1
|
|
Sustained release formulations containing methylglyoxal and their therapeutic applications
|
|
BRPI1003990A2
|
|
formulation for the treatment of fungal infections
|
|
CN101888836A
|
|
Oral drug delivery system based on poly dl- lactide-co-glycolide (plg) nano particles used for azole, moxifloxacin and rifampicin
|
|
AU2008361734A1
|
|
Poly DL-lactide-co-glycolide (PLG) nanoparticle based oral delivery system for Econazole moxifloxacin and refampicin
|
|
ZA200708247B
|
|
A process for the preparation of poly DI-Lactide-Co-Glycolide nanoparticles having antitubercular drugs encapsulated therein
|
|
BRPI0609126A2
|
|
inter and intra multilamellar vesicular composition
|
|
WO2006001035A2
|
|
Synergistic liposomal tamoxifen composition for topical application and method of preparing thereof.
|
|
AU2005251572A1
|
|
Sterol enriched mixed lammelarity Amphotericin intercalating liposomes in saline and the process for their preparation
|
|
US2010204243A1
|
|
Process for the Preparation of Poly DL-Lactide-Co-Glycolide Nanoparticles Having Antitubercular Drugs Encapsulated Therein
|
